Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Nabriva Therapeutics plc

NBRV•NASDAQ
Healthcare
Biotechnology
$1.42
$0.01(0.71%)
U.S. Market opens in 1h 30m

Nabriva Therapeutics plc (NBRV) Stock Overview

Explore Nabriva Therapeutics plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.5M
P/E Ratio-0.07
EPS (TTM)$-19.67
ROE-2.02%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

NBRV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nabriva Therapeutics plc (NBRV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.07 and a market capitalization of 4.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
125.40%
5-Day Change
77.50%
1-Month Change
N/A
3-Month Change
-11.80%
6-Month Change
-20.67%
Year-to-Date (YTD) Change
-29.00%
1-Year Change
-65.96%
3-Year Change
-99.08%
5-Year Change
-99.78%
All-Time (Max) Change
-99.57%

Contact Information

https://www.nabriva.com
353 1 649 2000
25-28 North Wall Quay, Dublin, NaN, 1

Company Facts

390 Employees
IPO DateJun 23, 2017
CountryIE

Frequently Asked Questions